The MyFID device combines modern smartphone technology with micro-tablets to improve the usage of medicines. The physician determines the dose and timing of medicine, but the patient has control over the device's functions. MyFID records the amount and time of each dose, as well as reasons for taking it and disease symptoms using easy-to-use scales. This information is available to both the patient and physician through a standardized treatment report, providing a more precise background for further treatment decisions. Sensidose AB's product line includes MYFID and FLEXILEV, and its system uses low-dose tablets retrieved through an automated dispenser with an inbuilt alarm.